Stay updated on ACTIV-5 / BET-B COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.
Latest updates to the ACTIV-5 / BET-B COVID-19 Clinical Trial page
- Check7 days agoChange DetectedUpgrade to v3.2.0 includes a prominent government funding and operating status notice; previous v3.1.0 has been removed. If no further changes to core content are present, expect updated operating status information to be authoritative.SummaryDifference1%
- Check14 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has undergone significant updates, including the addition of drug information for Remdesivir and details on Post-COVID Conditions, while also removing specific location details and certain drug classifications.SummaryDifference3%
- Check57 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to ACTIV-5 / BET-B COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.